BridgeBio Pharma
@BridgeBioPharma • 2,034 subscribers
We move at the speed of patient need. We exist to bring meaningful medicines to people living with genetic conditions. $BBIO
Videos
AI can't compress a clinical trial. It can't generate the data we don't have yet. Our CEO Neil Kumar pushed back on the AI hype with @bloomberg at #MIGlobal with Milken Institute – not because the tools aren't valuable, but because the years still take years.
BridgeBio Pharma56,374 Aufrufe • vor 2 Monaten
Millions of people living with #geneticdiseases are still waiting for treatments. At BridgeBio, our mission is to put patients first and push the boundaries of science to meet those needs. CEO Neil Kumar Ph.D., joined Deirdre Bolton at the Milken Institute Global Conference to highlight the urgency and opportunity in addressing rare and underserved conditions. Listen to the full video here:
BridgeBio Pharma117,611 Aufrufe • vor 1 Jahr
We are excited to announce that the U.S. FDA approved our orally-administered near-complete (≥90%) stabilizer of TTR for the treatment of adult patients with transthyretin cardiac amyloidosis (ATTR-CM). We are proud of the opportunity to serve patients within this community. Learn more:
BridgeBio Pharma43,642 Aufrufe • vor 1 Jahr
Keine weiteren Inhalte verfügbar